Results 221 to 230 of about 2,475,393 (270)
Some of the next articles are maybe not open access.

Potent Inhibitors of Dipeptidyl Peptidase iv and Their Mechanisms of Inhibition

2006
Dipeptidyl peptidase IV (DP IV) is a proline specific serine protease which cleaves Xaa-Pro-dipeptides from the N-terminus of longer peptides. A series of product analogous amino acid amides containing different structure modifications like substitution of a ring atom, variation of the ring size and/or the introduction of a thioxo amide bond, phosphono
A, Stöckel-Maschek   +5 more
openaire   +2 more sources

GLP-1 Agonists and Dipeptidyl-Peptidase IV Inhibitors

2011
Novel therapeutic options for type 2 diabetes based on the action of the incretin hormone glucagon-like peptide-1 (GLP-1) were introduced in 2005. Incretin-based therapies consist of two classes: (1) the injectable GLP-1 receptor agonists solely acting on the GLP-1 receptor and (2) dipeptidyl-peptidase inhibitors (DPP-4 inhibitors) as oral medications ...
openaire   +2 more sources

Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis

Therapeutic Advances in Endocrinology and Metabolism, 2021
Sanjay Kumar Bhadada   +2 more
exaly  

DIPEPTIDYL PEPTIDASE-IV INHIBITOR

2022
KURIMOTO MASAKI   +3 more
openaire   +1 more source

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga   +2 more
exaly  

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

Expert Opinion on Drug Safety, 2015
André Scheen
exaly  

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials

International Journal of Cardiology, 2016
Nathorn Chaiyakunapruk   +1 more
exaly  

Home - About - Disclaimer - Privacy